0001144204-15-007160.txt : 20150209
0001144204-15-007160.hdr.sgml : 20150209
20150209170816
ACCESSION NUMBER: 0001144204-15-007160
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150206
FILED AS OF DATE: 20150209
DATE AS OF CHANGE: 20150209
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alliqua BioMedical, Inc.
CENTRAL INDEX KEY: 0001054274
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 582349413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 CABOT BOULEVARD WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
BUSINESS PHONE: 215-702-8550
MAIL ADDRESS:
STREET 1: 2150 CABOT BOULEVARD WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
FORMER COMPANY:
FORMER CONFORMED NAME: Alliqua, Inc.
DATE OF NAME CHANGE: 20101222
FORMER COMPANY:
FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC
DATE OF NAME CHANGE: 20030529
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA CORP
DATE OF NAME CHANGE: 20030219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARTON BRADFORD
CENTRAL INDEX KEY: 0001618553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36278
FILM NUMBER: 15589379
MAIL ADDRESS:
STREET 1: C/O ALLIQUA BIOMEDICAL, INC.
STREET 2: 2150 CABOT BLVD. WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
4
1
v400818_4.xml
FORM 4
X0306
4
2015-02-06
0
0001054274
Alliqua BioMedical, Inc.
ALQA
0001618553
BARTON BRADFORD
C/O ALLIQUA BIOMEDICAL, INC.
2150 CABOT BLVD. WEST
LANGHORNE
PA
19047
0
1
0
0
Chief Operating Officer
Common Stock
2015-02-06
4
A
0
100000
0
A
115210
D
Stock Option (right to buy)
6.23
2015-02-06
4
A
0
115000
0
A
2025-02-06
Common Stock
115000
115000
D
Represents a restricted stock award that is subject to forfeiture until vested. This award vests in three equal annual installments, with one-third (1/3rd) vesting on each of February 6, 2016, February 6, 2017 and February 6, 2018, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and that certain restricted stock award agreement by and between the Issuer and Mr. Barton, effective as of February 6, 2015.
The option vests in three equal annual installments, with one-third (1/3rd) vesting and becoming exercisable on each of February 6, 2016, February 6, 2017 and February 6, 2018, subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan and Mr. Barton's continued service on the applicable vesting date.
/s/ Bradford Barton
2015-02-09